Publicaciones (56) Publicaciones de MARIA DEL CARMEN PEÑA CHILET

2024

  1. HMGA1 regulates trabectedin sensitivity in advanced soft-tissue sarcoma (STS): A Spanish Group for Research on Sarcomas (GEIS) study

    Cellular and Molecular Life Sciences, Vol. 81, Núm. 1

  2. The mechanistic functional landscape of retinitis pigmentosa: a machine learning-driven approach to therapeutic target discovery

    Journal of translational medicine, Vol. 22, Núm. 1, pp. 139

  3. drexml: A command line tool and Python package for drug repurposing

    Computational and Structural Biotechnology Journal, Vol. 23, pp. 1129-1143

2023

  1. A Comprehensive Analysis of 21 Actionable Pharmacogenes in the Spanish Population: From Genetic Characterisation to Clinical Impact

    Pharmaceutics, Vol. 15, Núm. 4

  2. A crowdsourcing database for the copy-number variation of the Spanish population

    Human Genomics, Vol. 17, Núm. 1

  3. An SPM-Enriched Marine Oil Supplement Shifted Microglia Polarization toward M2, Ameliorating Retinal Degeneration in rd10 Mice

    Antioxidants, Vol. 12, Núm. 1

  4. Crosstalk between Metabolite Production and Signaling Activity in Breast Cancer

    International Journal of Molecular Sciences, Vol. 24, Núm. 8

  5. Drug-target identification in COVID-19 disease mechanisms using computational systems biology approaches

    Frontiers in Immunology, Vol. 14

  6. Functional Profiling of Soft Tissue Sarcoma Using Mechanistic Models

    International Journal of Molecular Sciences, Vol. 24, Núm. 19

  7. Real-world evidence with a retrospective cohort of 15,968 COVID-19 hospitalized patients suggests 21 new effective treatments

    Virology Journal, Vol. 20, Núm. 1

  8. Visualization of automatically combined disease maps and pathway diagrams for rare diseases

    Frontiers in Bioinformatics, Vol. 3

  9. microRNAs-mediated regulation of insulin signaling in white adipose tissue during aging: Role of caloric restriction

    Aging Cell, Vol. 22, Núm. 11

2022

  1. Discovering potential interactions between rare diseases and COVID-19 by combining mechanistic models of viral infection with statistical modeling

    Human molecular genetics, Vol. 31, Núm. 12, pp. 2078-2089

  2. Towards a metagenomics machine learning interpretable model for understanding the transition from adenoma to colorectal cancer

    Scientific Reports, Vol. 12, Núm. 1

2021

  1. A DNA damage repair gene-associated signature predicts responses of patients with advanced soft-tissue sarcoma to treatment with trabectedin

    Molecular Oncology, Vol. 15, Núm. 12, pp. 3691-3705

  2. A comprehensive database for integrated analysis of omics data in autoimmune diseases

    BMC Bioinformatics, Vol. 22, Núm. 1

  3. A versatile workflow to integrate RNA-seq genomic and transcriptomic data into mechanistic models of signaling pathways

    PLoS Computational Biology, Vol. 17, Núm. 2

  4. COVID19 Disease Map, a computational knowledge repository of virus–host interaction mechanisms

    Molecular Systems Biology, Vol. 17, Núm. 10

  5. CSVS, a crowdsourcing database of the Spanish population genetic variability

    Nucleic acids research, Vol. 49, Núm. D1, pp. D1130-D1137

  6. Corrigendum to: COVID19 Disease Map, a computational knowledge repository of virus–host interaction mechanisms (Molecular Systems Biology, (2021), 17, 10, 10.15252/msb.202110387)

    Molecular Systems Biology